Literature DB >> 28943663

THE SYNTHESIS OF 13C9-15N-LABELED 3,5-DIIODOTHYRONINE AND THYROXINE.

Sarah A Hackenmueller1, Thomas S Scanlan1.   

Abstract

Thyroid hormones undergo extensive metabolism to regulate hormone activity. A labeled thyroid hormone would be useful to track hormone metabolism through various pathways. While radiolabeled thyroid hormones have been synthesized and used for in vivo studies, a stable isotope labeled form of thyroid hormone is required for studying thyroid hormone metabolism by LC-MS/MS, an analytical technique that has certain advantages without the complications of radioactivity. Here we report the synthesis of 13C9-15N-T2 and 13C9-15N-T4, two labeled thyroid hormone derivatives suitable for in vivo LC-MS/MS studies.

Entities:  

Keywords:  13C9-15N-T2; 13C9-15N-T4; thyroid hormone; thyroxine

Year:  2012        PMID: 28943663      PMCID: PMC5607869          DOI: 10.1080/00397911.2011.639005

Source DB:  PubMed          Journal:  Synth Commun        ISSN: 0039-7911            Impact factor:   2.007


  23 in total

Review 1.  Physiological and molecular basis of thyroid hormone action.

Authors:  P M Yen
Journal:  Physiol Rev       Date:  2001-07       Impact factor: 37.312

2.  Disappearance from serum of I131-labeled l-thyroxine and l-triiodothyronine in euthyroid subjects.

Authors:  K STERLING; J C LASHOF; E B MAN
Journal:  J Clin Invest       Date:  1954-07       Impact factor: 14.808

3.  A simple synthesis of [3,5-125I]Diiodo-L-thyroxine of high specific activity.

Authors:  K Sorimachi; H J Cahnmann
Journal:  Endocrinology       Date:  1977-10       Impact factor: 4.736

4.  Probing cell type-specific functions of Gi in vivo identifies GPCR regulators of insulin secretion.

Authors:  Jean B Regard; Hiroshi Kataoka; David A Cano; Eric Camerer; Liya Yin; Yao-Wu Zheng; Thomas S Scanlan; Matthias Hebrok; Shaun R Coughlin
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

Review 5.  Mechanisms of nongenomic actions of thyroid hormone.

Authors:  Paul J Davis; Jack L Leonard; Faith B Davis
Journal:  Front Neuroendocrinol       Date:  2007-10-05       Impact factor: 8.606

6.  Validation of a liquid chromatography-tandem mass spectrometry method to enable quantification of 3-iodothyronamine from serum.

Authors:  Andrea E DeBarber; Travis Geraci; Vincent P Colasurdo; Sarah A Hackenmueller; Thomas S Scanlan
Journal:  J Chromatogr A       Date:  2008-09-12       Impact factor: 4.759

7.  Development of a validated liquid chromatography/tandem mass spectrometry method for the distinction of thyronine and thyronamine constitutional isomers and for the identification of new deiodinase substrates.

Authors:  Susanne Piehl; Thomas Heberer; Gabor Balizs; Thomas S Scanlan; Josef Köhrle
Journal:  Rapid Commun Mass Spectrom       Date:  2008-10       Impact factor: 2.419

8.  3-Iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone.

Authors:  Thomas S Scanlan; Katherine L Suchland; Matthew E Hart; Grazia Chiellini; Yong Huang; Paul J Kruzich; Sabina Frascarelli; Dane A Crossley; James R Bunzow; Simonetta Ronca-Testoni; Emil T Lin; Daniel Hatton; Riccardo Zucchi; David K Grandy
Journal:  Nat Med       Date:  2004-05-16       Impact factor: 53.440

9.  Simultaneous measurement of thyroxine and triiodothyronine peripheral turnover kinetics in man.

Authors:  J T Nicoloff; J C Low; J H Dussault; D A Fisher
Journal:  J Clin Invest       Date:  1972-03       Impact factor: 14.808

10.  Determination of iodothyronine absorption and conversion of L-thyroxine (T 4 ) to L-triiodothyronine (T 3 ) using turnover rate techniques.

Authors:  M I Surks; A R Schadlow; J M Stock; J H Oppenheimer
Journal:  J Clin Invest       Date:  1973-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.